Skip to main content

November 2015

 

 

academics

 

Clinical research courses

Career opportunity for Junior Research Fellow in ICMR

Applications are invited for a post of a full time Junior Research Fellow leading to Ph.D. from University of Madras, under the guidance of Dr. K.R. Uma Devi at the Department of Bacteriology, NIRT Chennai. The candidate will be expected to work on genotypic and phenotypic characterization of clinical and laboratory strains of Mycobacterium tuberculosis in a biosafety level 3 facility for CDC funded project.

Looking for Scientist-C Non Medical in International Health Division

Applications are invited for the following temporary post in the ICMR Ad-hoc research project entitled, “Implementation and managing the activities under Indo-German (BMBF/HGF), Indo- France (INSERM), Indo-Canada (CIHR) and Indo-UK (MRC, LSHTM) MoUs etc.

Post: Scientist ‘C’ Non Medical – One

Pharma transpire 2016 International conference at Creative Educational Society’s College of Pharmacy

The college is established in the 2006 by creative educational society (CES). Kurnool founded by a group of academicians and professionals to impart the value based professional education. The college is located at chinnatekur on Hyderabad-Bangalore national high way-7, it is located about 13 Km from Kurnool. The institute is offering Bachelor degree in Pharmacy, Pharm. D, Post Baccarat (PB), Master degree with specializations 1.Pharmaceutics 2. Pharmaceutical Analysis and Quality Assurance 3. Pharmaceutical Chemistry 4. Pharmacology and also University recognized Research Center to pursue Ph.D affiliated to Jawaharlal Technical University Anantapur (J.N.T.U.A), approved by A.I.C.T.E, Pharmacy Council of India (P.C.I) and Recognized under section 2f & 12 b of UGC act.

Career opportunity for Quality Assurance: Manager level in Biocon

Biocon is a research-driven, global healthcare company with a strong matrix of capabilities along the biopharmaceutical value chain. Focusing on unmet medical needs in cancer, diabetes and inflammatory diseases, it offers novel therapies on a platform of affordable innovation.
Biocon together with group companies employs more than 2500 employees with approxmimately Rs 1,000 crore turnover and is expected to grow further during the current financial year.

Post: Qauality Assurance: Manager level

MANTHAN 2016: All India Online Essay Contest by IIHMR UNIVERSITY

The IIHMR University is a specialized Research University in management research, postgraduate education and training exclusively in the health sector. The university is ranked No. 1 B-School (Health Sector) in Outlook 2014, 2013, 2012, 2011 and No. 1 Institute in Healthcare Management in Hindustan Times. The University has been designated as WHO collaborating Center for District Health Systems based on Primary Health Care.

Opening for Pharmacists (132 Openings) in National Health Mission

For the effective implementation of National Health Mission in the State a separate Mission Directorate (NHM) has been created within the Directorate of Health headed by Mission Director. It has a Programme Management Unit (PMU) headed by a Deputy Director cum State Programme Officer and a Financial Management Unit (FMU) headed by Jt. Controller Finance. The Mission Directorate functions in close co-ordination with Directorate of Health and reports to the Principal Secretary (Health).

Career opportunity in QA, QC, Sales in Indian Drugs & Pharmaceuticals Ltd - Govt undetaking company

IDPL is the largest Central Pharma Public Sector Undertaking in India with plants at Rishikesh, Gurgaon & Hyderabad and two Subsidiary Units at Chennai and Muzaffarpur. IDPL is the largest Central Pharma Public Sector Undertaking in India. IDPL was established in 1961 as a role model in the healthcare with large monolithic infrastructure which facilitated in the evolution of Indian Pharmaceutical Industry as well as in the growth of pharmceutical units in the Private sector.

TESARO, Inc., an oncology-focused biopharmaceutical company, announced that VARUBI™ (rolapitant), an NK-1 receptor antagonist, is now available in the United States. The U.S. Food and Drug Administration (FDA) approved VARUBI on Sept. 1, 2015, for use in combination with other antiemetic agents in adults for the prevention of delayed nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, including, but not limited to, highly emetogenic chemotherapy.

Meridian Bioscience, Inc. announced it has received clearance from the U.S. Food and Drug Administration (FDA) for new claims for its illumigene® Pertussis molecular amplification test. The upgraded test reduces the effect of inhibitors in biologic samples and significantly expands Meridian’s customer base by including specimens collected by ESwab™ (Copan Diagnostics, Inc.).
ESwab is a multipurpose universal transport system that a significant portion of laboratories in the United States currently use to streamline workflows and eliminate costs associated with stocking multiple swab types.